- 4009 Hackney Springs Ln, Sachse, TX 75048
Molecular Diagnostics & Genetics Billing Services
TransLabs delivers comprehensive billing and revenue cycle management services designed exclusively for molecular diagnostics and genetics laboratories performing next-generation sequencing, PCR-based testing, FISH analysis, pharmacogenomics, hereditary cancer screening, carrier testing, and advanced genomic diagnostics.
Molecular diagnostics billing requires specialized expertise in CPT 81000-series coding, Tier 1/Tier 2 classification, PLA codes, multi-gene panel optimization, and LDT documentation. TransLabs’ certified molecular specialists manage genomic sequencing, payer-specific hereditary testing policies, and molecular pathology guidelines to maximize reimbursement and ensure compliance.
Our Performance Metrics Demonstrate Excellence:
Molecular diagnostics and genetics laboratory billing covers the full revenue cycle for complex genomic testing, including next-generation sequencing, single-gene analyses, pharmacogenomic testing, infectious disease diagnostics, and hereditary cancer screening. These labs face unique hurdles.
TransLabs specializes in these unique Molecular Diagnostics & Genetics challenges:
Expert selection across 500+ molecular pathology codes for every test type your lab runs.
Precise analyte classification with correct variant and sequence analysis applied to every claim.
Multiple molecular tests coded for compliant reimbursement without bundling violations.
Accurate proprietary code application with validated test-specific requirements.
Complete validation records and regulatory documentation supporting every test billed.
Clinical documentation tying genetic testing to patient history, prior results, and guidelines.
From commercial insurers to Medicare and Medicaid, our specialists have the lab-exclusive billing expertise to get your claims paid across every network, every time.
TransLabs provides expert billing and coding for the full spectrum of molecular diagnostics and genetics testing:
Our molecular-specific RCM platform manages every stage of your financial cycle, from test ordering through final payment collection. Built around the unique complexity of genomic billing, it closes coding gaps, prevents denials before they happen, and keeps your lab's revenue optimized at every step.
Our certified molecular pathology coders bring specialized expertise across the full CPT 81000-series, PLA codes, and ICD-10 assignment for every genomic testing specialty your lab performs. Accurate code selection on every claim means fewer rejections and stronger reimbursement.
Our A/R team runs a structured follow-up process built specifically for pathology, covering professional component denials, split-billing disputes, and coordination of benefits issues. Clients typically see a 35% reduction in AR days.
We manage complete payer enrollment, CLIA high-complexity certification tracking, CAP molecular pathology accreditation, and network participation setup across all carrier types. Our credentialing team keeps your lab's certifications current and your providers enrolled.
Complex genomic claims require precision that general billing teams simply cannot provide. We process molecular claims at volume with a 96% clean claims rate, full PLA code validation, and a consistent 24 to 48 hour submission turnaround, including urgent molecular tests.
Molecular denials are among the most difficult and highest-value in all of laboratory billing. Our appeals team specializes in medical necessity disputes, experimental and investigational determinations, and LDT coverage challenges, achieving an 90% success rate.
We manage comprehensive pre-authorization for hereditary cancer panels, pharmacogenomics, and high-cost molecular tests before orders are processed. Our team also coordinates peer-to-peer physician support when payers push back, protecting your lab's ability to bill and collect.
Our intelligent RPA solutions automate the repetitive, high-stakes tasks in molecular billing including eligibility checks, stacking rule validation, claim scrubbing, and status follow-up. The result is 70% fewer manual coding tasks, claims processed three times faster, and errors eliminated from your workflow.
We provide operational support that goes well beyond billing, including test menu optimization, turnaround time improvement, and genetic counseling integration. Whether your lab is scaling its molecular offerings or tightening existing workflows, we bring the expertise to support growth.
Our front office team manages test requisition intake, genetic counseling coordination, insurance verification, ordering provider education, and patient financial counseling with the precision molecular testing demands. A clean, well-managed front end means fewer downstream claim problems and a better experience.
Our HIPAA-compliant structured reporting service covers genomic findings, variant interpretation documentation, and family cascade testing recommendations. Every report is handled by professionals fluent in molecular terminology, ensuring your documentation supports compliant billing and meets clinical standards.
Our complimentary 90-day audit examines your coding patterns, stacking opportunities, denial history, and medical necessity documentation to identify exactly where revenue is being lost. Most labs uncover between $50,000 and $200,000 or more in recoverable annual revenue.
CPT 81000-series, PLA codes, NGS, and genomic sequencing expertise.
Precise single versus multi-analyte classification and correct code selection.
Maximum compliant reimbursement across multi-gene panels without bundling violations.
Complete analytical and clinical validation records supporting every lab-developed test.
Real-time coverage tracking across 5,000+ payers .
98% clean claims, 90% appeal success, and 30 to 45% revenue increases within 90 days.
TransLabs optimizes your molecular laboratory revenue cycle through systematic best practices that ensure maximum reimbursement and regulatory compliance.
Stacking Rules Optimization
Correct CPT sequencing across multiple molecular tests, maximizing compliant reimbursement while preventing bundling violations.
Medical Necessity Documentation
Genetic testing linked to NCCN and ACMG guidelines with comprehensive patient history and appeal-ready clinical rationale.
PLA Code Validation
Quarterly verification of PLA assignments with confirmed test-specific requirements and correct proprietary code application.
LDT Compliance Management
Complete analytical and clinical validation documentation with CLIA high-complexity certification maintained for all reported variants.
Prior Authorization Protocols
Payer-specific pre-authorization with comprehensive clinical documentation, genetic counselor attestations, and turnaround tracking to prevent testing delays.
Our certified molecular pathology coders specialize in the full 500+ CPT 81000-series, covering Tier 1 and Tier 2 classification, genomic sequencing procedures, gene-specific versus unlisted codes, constitutional versus somatic testing, and PLA code application. We maintain 96% coding accuracy on first submission.
Stacking rules govern how multiple molecular tests on the same specimen are coded together. We optimize sequencing across Tier 1 and Tier 2 combinations, document medical necessity for each component, and account for payer-specific stacking policies. Our approach typically increases molecular revenue by 20 to 35%.
We build medical necessity documentation around NCCN and ACMG guidelines, personal and family history, prior testing gaps, risk assessment scores, and genetic counselor attestations. This approach achieves an 89% success rate on appealed molecular claim denials.
Yes. We manage complete analytical and clinical validation documentation, CLIA high-complexity certification, appropriate CPT or Tier 2 code selection, and payer coverage support, while providing proven appeal strategies for LDT denials backed by clinical utility evidence.
We monitor every quarterly AMA PLA release, update billing systems immediately, verify test-specific documentation requirements, and support payer coverage policy development for newly assigned codes. Your proprietary tests are always billed with current, accurate PLA codes.
We cover all genomic sequencing procedures including 81435, 81437, and 81439, with correct gene count thresholds, bioinformatics pipeline documentation, germline versus somatic billing, secondary findings reporting, and liquid biopsy coding. Both technical and clinical validation documentation are fully supported.
